KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer (Q38854561)
Jump to navigation
Jump to search
scientific article published on July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer |
scientific article published on July 2015 |
Statements
1 reference
KRAS exon 2 mutations influence activity of regorafenib in an SW48-based disease model of colorectal cancer (English)
1 reference
Peter Camaj
1 reference
Stefano Primo
1 reference
Yan Wang
1 reference
Volker Heinemann
1 reference
Yue Zhao
1 reference
Ruediger Paul Laubender
1 reference
Sebastian Stintzing
1 reference
Clemens Giessen-Jung
1 reference
Andreas Jung
1 reference
Sebastian Gamba
1 reference
Christiane Josephine Bruns
1 reference
Dominik Paul Modest
1 reference
1 July 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference